The stock of Amryt Pharma PLC (LON:AMYT) is a huge mover today! The stock decreased 3.23% or GBX 0.5 on November 8, hitting GBX 15. About 67,627 shares traded hands. Amryt Pharma PLC (LON:AMYT) has declined 91.86% since April 8, 2016 and is downtrending. It has underperformed by 93.82% the S&P500.
The move comes after 8 months positive chart setup for the GBX 32.32M company. It was reported on Nov, 8 by Barchart.com. We have GBX 30.00 PT which if reached, will make LON:AMYT worth GBX 32.32 million more.
Amryt Pharma plc, formerly Fastnet Equity plc, is a United Kingdom specialty pharmaceutical company. The company has a market cap of 32.32 million GBP. The Firm focuses on developing and delivering treatments for patients with rare and orphan diseases. It currently has negative earnings. The Company’s products include Episalvan and Imlan.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.